2-[3-[[6-[[1-(2,2-difluoroethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]piperidin-1-yl]acetonitrile

C18H21F2N9 — CID 54579115

IUPAC2-[3-[[6-[[1-(2,2-difluoroethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]piperidin-1-yl]acetonitrile
SMILESN#CCN1CCCC(Cn2ncc3cnc(Nc4cnn(CC(F)F)c4)nc32)C1
InChIInChI=1S/C18H21F2N9/c19-16(20)12-28-11-15(8-23-28)25-18-22-6-14-7-24-29(17(14)26-18)10-13-2-1-4-27(9-13)5-3-21/h6-8,11,13,16H,1-2,4-5,9-10,12H2,(H,22,25,26)
InChIKeyMXDPWRQUJXIYGV-UHFFFAOYSA-N
MW401.43 g/mol
LogP2.27
Rot. Bonds7

About 2-[3-[[6-[[1-(2,2-difluoroethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]piperidin-1-yl]acetonitrile

2-[3-[[6-[[1-(2,2-difluoroethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]piperidin-1-yl]acetonitrile (PubChem CID 54579115) has the molecular formula C18H21F2N9 and a molecular weight of 401.43 g/mol. Its IUPAC name is 2-[3-[[6-[[1-(2,2-difluoroethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]piperidin-1-yl]acetonitrile.

Molecular Properties

Compound Name2-[3-[[6-[[1-(2,2-difluoroethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]piperidin-1-yl]acetonitrile
PubChem CID54579115
Molecular FormulaC18H21F2N9
Molecular Weight401.43 g/mol
Exact Mass401.19
IUPAC Name2-[3-[[6-[[1-(2,2-difluoroethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]piperidin-1-yl]acetonitrile
SMILESN#CCN1CCCC(Cn2ncc3cnc(Nc4cnn(CC(F)F)c4)nc32)C1
InChIInChI=1S/C18H21F2N9/c19-16(20)12-28-11-15(8-23-28)25-18-22-6-14-7-24-29(17(14)26-18)10-13-2-1-4-27(9-13)5-3-21/h6-8,11,13,16H,1-2,4-5,9-10,12H2,(H,22,25,26)
InChIKeyMXDPWRQUJXIYGV-UHFFFAOYSA-N
XLogP2.27
TPSA100.48 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500401.43
LogP ≤ 52.27
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'cyanamide', 'substructure': 'N/A'}

Analyze 2-[3-[[6-[[1-(2,2-difluoroethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]piperidin-1-yl]acetonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[3-[[6-[[1-(2,2-difluoroethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]piperidin-1-yl]acetonitrile?
The IUPAC name of 2-[3-[[6-[[1-(2,2-difluoroethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]piperidin-1-yl]acetonitrile (CID 54579115) is 2-[3-[[6-[[1-(2,2-difluoroethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]piperidin-1-yl]acetonitrile.
What is the SMILES notation for 2-[3-[[6-[[1-(2,2-difluoroethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]piperidin-1-yl]acetonitrile?
The canonical SMILES for 2-[3-[[6-[[1-(2,2-difluoroethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]piperidin-1-yl]acetonitrile is N#CCN1CCCC(Cn2ncc3cnc(Nc4cnn(CC(F)F)c4)nc32)C1.
What is the InChIKey of 2-[3-[[6-[[1-(2,2-difluoroethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]piperidin-1-yl]acetonitrile?
The InChIKey is MXDPWRQUJXIYGV-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H21F2N9/c19-16(20)12-28-11-15(8-23-28)25-18-22-6-14-7-24-29(17(14)26-18)10-13-2-1-4-27(9-13)5-3-21/h6-8,11,13,16H,1-2,4-5,9-10,12H2,(H,22,25,26).
What are the key properties of 2-[3-[[6-[[1-(2,2-difluoroethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]piperidin-1-yl]acetonitrile?
2-[3-[[6-[[1-(2,2-difluoroethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]piperidin-1-yl]acetonitrile has a molecular weight of 401.43 g/mol, XLogP of 2.27, 7 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-[[6-[[1-(2,2-difluoroethyl)pyrazol-4-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]methyl]piperidin-1-yl]acetonitrile is sourced from PubChem (CID 54579115), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).